BBL
MRVI icon

Beck Bode LLC’s Maravai LifeSciences MRVI Stock Holding History

Beck Bode LLC’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-178,916
Closed -$5.08M – 244
2022
Q2 		$5.08M Buy
178,916
+10,947
+7% +$347K 1.08% 28
2022
Q1 		$5.92M Buy
167,969
+2,032
+1% +$68.1K 1.33% 23
2021
Q4 		$6.95M Buy
165,937
+5,873
+4% +$238K 1.74% 27
2021
Q3 		$7.86M Buy
+160,064
New +$7.81M 2.19% 20

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

Beck Bode LLC's MRVI Position: Q3 2022 in Review

Beck Bode LLC sold out of Maravai LifeSciences (MRVI) in Q3 2022, closing a stake of 178,916 shares — an estimated $5.08M sold.

Beck Bode LLC first reported a position in MRVI in Q3 2021 and held it in 4 quarters. The position peaked at $7.86M in Q3 2021. 202 funds tracked by Wall St. Rank hold MRVI as of Q3 2022.

  • Beck Bode LLC reported no remaining Maravai LifeSciences position as of Q3 2022 after selling out during the quarter.
  • Beck Bode LLC sold 178,916 Maravai LifeSciences shares in Q3 2022, an estimated $5.08M.
  • Beck Bode LLC first reported a position in Maravai LifeSciences in Q3 2021 and held it in 4 quarters.
  • Beck Bode LLC's Maravai LifeSciences position peaked at $7.86M in Q3 2021.
  • 202 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2022.

Based on Beck Bode LLC's 13F filing for Q3 2022, filed 14 Nov 2022.